In a bullish move, RBC Capital has upped its price target on Boston Scientific from $120 to $125, signaling strong confidence ...

AE Wealth Management LLC dramatically reduced its stake in Starbucks Corporation, selling off 46.9% of its holdings which ...

Bristol Myers Squibb is taking a strategic leap, offloading five immunology assets, including three in clinical stages, to a ...

As KLAC’s AI models roll out new trading strategies, investors are eyeing potential gains. Each strategy incorporates ...

Avantax Advisory Services Inc. has significantly increased its investment in CVS Health, purchasing an additional 32,873 ...

Phoenix Financial Ltd turned heads with a bold move, slashing its TJX stake by a hefty 34.7%. Not deterred by this, TJX ...

Etsy’s CEO Josh Silverman is making headlines with his recent sale of 140,000 shares, sparking debates over his intentions.

Airbnb's latest analyst forecast sets a bullish tone with a $156 price target from UBS analyst Stephen Ju. Amid a flurry of ...

Vertex Pharmaceuticals is set to unveil its Q2 2025 earnings on August 4, highlighting its stronghold in rare disease ...

Mondelez International experienced a notable surge in options trading, with a 158% increase in put options acquired by ...

Mackenzie Financial Corp trimmed its holdings in Marsh & McLennan by 5%, now owning 731,080 shares worth roughly $178.41 ...

Southwest Airlines, once a titan of budget air travel, is navigating through some turbulent skies. For 47 consecutive years, ...